These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38969347)

  • 1. Survival of stage III non-seminoma testis cancer patients versus simulated controls, according to race/ethnicity.
    Morra S; Cano Garcia C; Piccinelli ML; Tappero S; Barletta F; Incesu RB; Scheipner L; Baudo A; Tian Z; de Angelis M; Mirone V; Califano G; Celentano G; Saad F; Shariat SF; Chun FKH; de Cobelli O; Musi G; Terrone C; Briganti A; Tilki D; Ahyai S; Carmignani L; Longo N; Karakiewicz PI
    Int J Urol; 2024 Oct; 31(10):1137-1143. PubMed ID: 38969347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls.
    Morra S; Piccinelli ML; Cano Garcia C; Tappero S; Barletta F; Incesu RB; Scheipner L; Baudo A; Tian Z; Saad F; Mirone V; Califano G; Colla' Ruvolo C; Shariat SF; de Cobelli O; Musi G; Chun FKH; Terrone C; Briganti A; Tilki D; Ahyai S; Carmignani L; Longo N; Karakiewicz PI
    Int Urol Nephrol; 2023 Dec; 55(12):3119-3128. PubMed ID: 37640983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States.
    Cano Garcia C; Nimer N; Piccinelli ML; Tappero S; Panunzio A; Barletta F; Incesu RB; Tian Z; Saad F; Kapoor A; Briganti A; Terrone C; Shariat SF; Tilki D; Antonelli A; De Cobelli O; Kluth LA; Becker A; Chun FKH; Karakiewicz PI
    Ann Epidemiol; 2023 Mar; 79():65-70. PubMed ID: 36640918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival differences in non-seminoma testis cancer patients according to race/ethnicity.
    Incesu RB; Barletta F; Tappero S; Piccinelli ML; Garcia CC; Morra S; Scheipner L; Tian Z; Saad F; Shariat SF; Ahyai S; Longo N; Chun FKH; de Cobelli O; Terrone C; Briganti A; Tilki D; Graefen M; Karakiewicz PI
    Cancer Epidemiol; 2024 Apr; 89():102538. PubMed ID: 38377946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Prognostic Factors of Racial Disparities in Testicular Germ Cell Tumor Survival in the United States (1992-2015).
    Wu J; Ji YB; Tang BW; Brown M; Wang BH; Du CL; Du JS; Wang XM; Cai LJ; Wu GY; Zhou Y
    Biomed Environ Sci; 2021 Feb; 34(2):152-162. PubMed ID: 33685574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival in patients with germ cell testicular cancer: a population-based competing-risks regression analysis.
    Gandaglia G; Becker A; Trinh QD; Abdollah F; Schiffmann J; Roghmann F; Tian Z; Montorsi F; Briganti A; Karakiewicz PI; Sun M
    Eur J Surg Oncol; 2014 Jan; 40(1):103-12. PubMed ID: 24099755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis.
    Sun M; Abdollah F; Liberman D; Abdo A; Thuret R; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    Cancer; 2011 Sep; 117(18):4277-85. PubMed ID: 21387261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.
    Ghazarian AA; Kelly SP; Altekruse SF; Rosenberg PS; McGlynn KA
    Cancer; 2017 Jun; 123(12):2320-2328. PubMed ID: 28241106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinoma.
    Piccinelli ML; Garcia CC; Panunzio A; Tappero S; Barletta F; Incesu RB; Tian Z; Luzzago S; Mistretta FA; Ferro M; Saad F; Shariat SF; Graefen M; Briganti A; Terrone C; Antonelli A; Chun FKH; de Cobelli O; Musi G; Karakiewicz PI
    J Surg Oncol; 2024 Aug; ():. PubMed ID: 39183540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent trends in the incidence of testicular germ cell tumors in the United States.
    Ghazarian AA; Trabert B; Devesa SS; McGlynn KA
    Andrology; 2015 Jan; 3(1):13-8. PubMed ID: 25331158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity.
    Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Hoeh B; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
    Int Urol Nephrol; 2022 Jul; 54(7):1521-1527. PubMed ID: 35508792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial Comment to: "Survival of stage III non-seminoma testis cancer patients versus simulated controls, according to race/ethnicity".
    Würnschimmel C; Afferi L; Wenzel M
    Int J Urol; 2024 Oct; 31(10):1143-1144. PubMed ID: 39104298
    [No Abstract]   [Full Text] [Related]  

  • 13. Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors.
    Palumbo C; Mistretta FA; Mazzone E; Knipper S; Tian Z; Perrotte P; Antonelli A; Montorsi F; Shariat SF; Saad F; Simeone C; Briganti A; Lattouf JB; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Oct; 17(5):e1026-e1035. PubMed ID: 31378580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional Differences in Stage III Nonseminoma Germ Cell Tumor Patients Across SEER Registries.
    Cano Garcia C; Barletta F; Tappero S; Piccinelli ML; Incesu RB; Morra S; Scheipner L; Tian Z; Saad F; Shariat SF; Ahyai S; Longo N; Tilki D; De Cobelli O; Terrone C; Briganti A; Banek S; Kluth LA; Chun FKH; Karakiewicz PI
    Clin Genitourin Cancer; 2024 Oct; 22(5):102161. PubMed ID: 39147612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients.
    Würnschimmel C; Collà Ruvolo C; Nocera L; Wenzel M; Tian Z; Saad F; Briganti A; Shariat SF; Mirone V; Chun FKH; Tilki D; Graefen M; Karakiewicz PI
    Eur Urol Focus; 2022 Jan; 8(1):191-199. PubMed ID: 33610487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States.
    Rahman R; Schmaltz C; Jackson CS; Simoes EJ; Jackson-Thompson J; Ibdah JA
    Cancer Med; 2015 Dec; 4(12):1863-70. PubMed ID: 26471963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy.
    Mazzone E; Mistretta FA; Knipper S; Tian Z; Palumbo C; Gandaglia G; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Dec; 17(6):e1153-e1162. PubMed ID: 31515197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences among boys with testicular germ cell tumors in the United States.
    Walsh TJ; Davies BJ; Croughan MS; Carroll PR; Turek PJ
    J Urol; 2008 May; 179(5):1961-5. PubMed ID: 18355842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in overall survival of penile cancer patients versus population-based controls.
    Scheipner L; Tappero S; Piccinelli ML; Barletta F; Garcia CC; Incesu RB; Morra S; Tian Z; Saad F; Shariat SF; Terrone C; De Cobelli O; Briganti A; Chun FKH; Tilki D; Longo N; Seles M; Ahyai S; Karakiewicz PI
    Int J Urol; 2024 Mar; 31(3):274-279. PubMed ID: 38014575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer.
    Wenzel M; Deuker M; Stolzenbach F; Nocera L; Collà Ruvolo C; Tian Z; Shariat SF; Saad F; Briganti A; Kluth LA; Chun FKH; Karakiewicz PI
    Urol Oncol; 2021 Jun; 39(6):369.e9-369.e17. PubMed ID: 33309509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.